This site is intended for healthcare professionals only
LoginRegister
Lupin, Natco Launch Bosentan Tablets in US With 180-Day ExclusivityLupin Gets Rs 18 Crore Relief as HC Bars Arbitrary Tax Reassessment
Zydus Lifesciences gets NOC from Health Canada for ZDS-Varenicline tabletsZydus Lifesciences secures USFDA nod for Ibuprofen, Famotidine Tablets for rheumatoid arthritis
Abbott India Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy to step downAbbott India Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy...
Lupin rolls out Loteprednol Etabonate Ophthalmic Suspension in USUSFDA issues EIR for Lupin Somerset facility
Sanofi nears selling 50 percent controlling stake in Opella to CD&RSanofi nears selling 50 percent controlling stake in Opella to CD&R
Kerala: Health Minister Veena George to inaugurate first ever project on collection, disposal of expired medicinesKerala: Health Minister Veena George to inaugurate first ever project on collection, disposal of...
Hetero Biopharma Gets CDSCO Panel Nod for Phase IV Trial of Denosumab Injection in Cancer PatientsHetero Labs Gets CDSCO Panel Nod To Study Antipsychotic Drug Brexpiprazole Tablets
ED attaches Telangana pharma firm assets for illegal export of drugsED attaches Telangana pharma firm assets for illegal export of drugs
Action taken against 694 manufacturing units since 2022: MinisterFolic Acid Dosage Mislabeling: CDSCO Panel Proposes Urgent Correction in Drug Rules
USFDA issues 2 observattions for Cipla arm Mahape facilityUSFDA issues 2 observations for Cipla arm Mahape facility
Govt extends deadline for submitting applications under PLI SchemeCipla bags USFDA nod for chronic myeloid leukemia drug Nilotinib
Dr Reddys Gets CDSCO Panel Nod To Import, Market Saccharomyces Boulardii, BE, CT WaivedDr Reddy's Laboratories Gets CDSCO Panel Nod To Study Semaglutide in Type 2 Diabetes Mellitus
X